Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
得意分野
Suggested News & Insights
SFC Enforcement Reinforces Approach To Due Diligence on Third-Party Systems, Client Transaction Monitoring, AML LiabilityOctober 13, 2026Sidley Named a Finalist for “Most Impressive Global Investigations Practice of the Year” at the 2026 GIR AwardsOctober 9, 2026SEC Division of Examinations Issues Exam HandbookOctober 7, 2026Court Grants Summary Judgment in Kickback-Based FCA Case, Holding Relator Failed to Prove Remuneration or WillfulnessOctober 7, 2026Sidley Represents GE HealthCare in Its US$945 Million Acquisition of SOFIE BiosciencesOctober 7, 2026DOJ’s National Fraud Enforcement Division Issues First Corporate Enforcement PrioritiesOctober 2, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory